QuarterHawkSign in

Alignment Healthcare, Inc. (ALHC)

Healthcare

No action
Fundamental
3
Sentiment
2
Technical
2

Do Nothing: qualitativeScore is 2 (below required floor of 3), and confirmed earnings on 2026-07-30 falls inside the 15-trading-day holding window, so no fresh bullish entry is allowed.

Analysis as of 2026-07-09· about 2 trading days ago

Company overview

Alignment Healthcare, Inc. is a technology-driven provider of Medicare Advantage plans, focusing on personalized medical services for elderly individuals in the U.S. The company operates its own Medicare Advantage programs in California, North Carolina, and Nevada, and also provides healthcare services for other Medicare Advantage plans.

Fundamental

fair
Fundamental3
Improving fundamentals

Alignment Healthcare shows strong growth and liquidity, but faces margin and regulatory risks.

Score 3/5 (Mixed but improving): SEC filings show strong Medicare Advantage membership/revenue growth and a turn to GAAP profitability in 1H 2026 with solid liquidity (cash ~$694M, undrawn revolver). Valuation looks cheap on sales (EV/Sales ~0.53x) but earnings power is still thin (TTM net margin ~0.9%, EV/EBITDA ~27.8x, P/E ~67.9x) and the business remains exposed to CMS reimbursement/regulatory changes and competitive pressure.

Sentiment

weak
Sentiment2
Neutral sentiment

Sentiment is neutral with legal chatter dominating discussions.

Near-term catalyst visibility is low: the last-30d GlobeNewswire feed was dominated by plaintiff-law-firm “securities fraud investigation” solicitations (excluded), leaving only a recent, bearish insider-sale headline (reported 2026-06-30; announced; partially priced) as an actionable datapoint. Media sentiment is neutral and slightly softer than the 30–90d baseline, retail discussion is mixed but tilted toward legal-chatter, and while no regulator-confirmed investigation was found, moderate promo/solicitation noise keeps conviction capped (≤3).

Technical

weak
Technical2
Bearish short-term trend

The stock broke below key averages, indicating a bearish short-term trend.

Score 2/5: ALHC is still above its 50/200-day bases near 19.10, but the latest 3.65x-ATR selloff closed beneath SMA20, EMA9, EMA21, and daily VWAP on heavy volume. RSI reset to 45.20, Williams %R dropped to -90.57, and MACD slipped below its signal while staying above zero, leaving only a bounce-watch rather than a confirmed bullish entry.

You’re looking at 2026-07-09 — about 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.